Previous research has shown that cellular models of Barth syndrome (Taz knockout C2C12 myoblasts and Barth syndrome patient-derived lymphocytes) have reduced levels of MCU and that CL is required for proper MCU activity (Ghosh et al., 2020). The gene discussed is TAFAZZIN; the disease is Barth syndrome.